NEW YORK – Gestalt Diagnostics said today that it has entered two strategic collaborations for cancer pathology testing.

The firm said that it is collaborating with Westminster, Colorado-based Flagship Biosciences to develop an integrated workflow that gives pathologists access to Flagship's analysis services for digital images to support PD-L1 testing.